However, the precise role of IFN-β in controlling oxidative stress in MS is uncertain, particularly given that type I IFN activates iNOS in monocytes and promotes ROS generation [19], [20], while it can also downregulate iNOS expression in other settings [21]. Here, IFNB1 is linked to myeloid sarcoma.